Envestnet Portfolio Solutions Inc. reduced its holdings in shares of Leidos Holdings, Inc. (NYSE:LDOS - Free Report) by 12.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 46,371 shares of the aerospace company's stock after selling 6,480 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in Leidos were worth $6,680,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of the business. FMR LLC lifted its holdings in shares of Leidos by 27.8% in the third quarter. FMR LLC now owns 2,405,726 shares of the aerospace company's stock worth $392,133,000 after acquiring an additional 522,764 shares during the last quarter. JPMorgan Chase & Co. increased its position in Leidos by 13.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,504,392 shares of the aerospace company's stock worth $571,216,000 after purchasing an additional 405,256 shares in the last quarter. Raymond James Financial Inc. bought a new position in Leidos in the 4th quarter valued at approximately $40,402,000. Jupiter Asset Management Ltd. boosted its position in Leidos by 625.4% in the fourth quarter. Jupiter Asset Management Ltd. now owns 281,452 shares of the aerospace company's stock valued at $40,546,000 after buying an additional 242,651 shares in the last quarter. Finally, Van ECK Associates Corp grew its stake in shares of Leidos by 39.9% during the fourth quarter. Van ECK Associates Corp now owns 841,479 shares of the aerospace company's stock worth $121,223,000 after buying an additional 239,846 shares during the last quarter. 76.12% of the stock is currently owned by institutional investors.
Leidos Trading Down 0.9 %
Shares of LDOS traded down $1.19 during trading hours on Friday, hitting $133.66. 3,989,747 shares of the stock were exchanged, compared to its average volume of 1,082,379. The firm has a market capitalization of $17.14 billion, a P/E ratio of 14.46, a price-to-earnings-growth ratio of 1.65 and a beta of 0.72. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.21 and a quick ratio of 1.13. Leidos Holdings, Inc. has a fifty-two week low of $123.23 and a fifty-two week high of $202.90. The business has a 50-day moving average of $139.69 and a 200-day moving average of $154.48.
Leidos (NYSE:LDOS - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The aerospace company reported $2.37 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.13. Leidos had a return on equity of 30.93% and a net margin of 7.53%. On average, research analysts expect that Leidos Holdings, Inc. will post 10.62 EPS for the current year.
Leidos Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Shareholders of record on Friday, March 14th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend is Friday, March 14th. Leidos's dividend payout ratio (DPR) is presently 17.32%.
Insiders Place Their Bets
In other news, Director Gary Stephen May sold 2,128 shares of the stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $131.24, for a total transaction of $279,278.72. Following the transaction, the director now owns 11,264 shares of the company's stock, valued at $1,478,287.36. This represents a 15.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Robert C. Kovarik, Jr. sold 1,511 shares of the firm's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $134.56, for a total value of $203,320.16. Following the completion of the sale, the director now owns 6,408 shares of the company's stock, valued at approximately $862,260.48. This represents a 19.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.96% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on LDOS. TD Cowen cut Leidos from a "buy" rating to a "hold" rating and dropped their price target for the company from $200.00 to $165.00 in a research note on Wednesday, January 8th. StockNews.com downgraded Leidos from a "strong-buy" rating to a "buy" rating in a research report on Saturday, March 8th. Truist Financial reduced their price target on Leidos from $185.00 to $165.00 and set a "buy" rating on the stock in a report on Wednesday, February 12th. William Blair downgraded Leidos from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Finally, The Goldman Sachs Group downgraded shares of Leidos from a "buy" rating to a "neutral" rating and cut their target price for the stock from $228.00 to $153.00 in a research report on Thursday, December 12th. Six investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $178.07.
View Our Latest Analysis on LDOS
Leidos Profile
(
Free Report)
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
See Also

Before you consider Leidos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leidos wasn't on the list.
While Leidos currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report